Prognose

Vi har ingen analytikerdata for denne virksomhed.

Nyheder Til nyhedsfeedet

Innovate Corp increases Q4 revenue significantly and reduces net loss

Innovate Corp reports Q4 2025 revenue increased 61.7% to $382.7 million with a net loss of $7.8 million, improved from $16.9 million a year earlier. The infrastructure segment drove growth with a 65.7% gain, while the life‑sciences segment suffered from inventory shortages. Cash rose to $112.1 million and MediBeacon received FDA approval for a new TGFR system. The company expects further growth from product approvals and market expansion but sees risks from supply bottlenecks and higher liabilities. » Mere på de.investing.com

I 2026 har Innovate Corp allerede udloddet 0,67 € i udbytte. Den seneste udlodning fandt sted i april.

I det seneste kvartal havde Innovate Corp en omsætning på 369,41 mio. € og et nettoresultat på 9,38 mio. €